Medical Device News Magazine

SIR Foundation Receives Major Gift to Support Research Grants and Panel on Uterine Health

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The Society of Interventional Radiology (SIR) Foundation announced a major gift from John Lipman, MD, FSIR, of Atlanta, that will propel uterine fibroid research forward. This gift will support four years of funding for SIR Foundation’s newly announced Dr. Scott C. Goodwin Uterine Artery Embolization Grant and five years of funding for the Dr. James B. Spies Global Summit on Uterine Fibroid and Adenomyosis Research. The announcement was made at the SIR Foundation Gala on March 5 during the SIR 2023 Annual Scientific Meeting.

The Dr. Scott C. Goodwin Uterine Artery Embolization Grant is focused on advancing uterine fibroid and uterine artery embolization research and will launch in October 2023. The first Dr. James B. Spies Global Summit on Uterine Fibroid and Adenomyosis Research will be hosted in June 2023.

“Research into uterine fibroids and adenomyosis and the minimally invasive treatments that can address these conditions, such as uterine artery embolization, are invaluable in providing care to women,” said SIR Foundation Board Chair Theresa M. Caridi, MD, FSIR. “We are incredibly grateful to Dr. Lipman for his personal commitment to advancing the future of interventional radiology for patients and our colleagues in all practice settings.”

Scott C. Goodwin, MD, FSIR, and James B. Spies, MD, FSIR, are highly regarded pioneers of uterine fibroid research, having led the SIR Foundation’s Fibroid Registry, the largest collection of data on uterine fibroids, and conducted foundational research into uterine artery embolization. Dr. Goodwin and Dr. Spies are long-term members of the SIR, having each served as SIR president, as well as members of SIR Foundation’s leadership.

Dr. Lipman is a widely recognized expert on uterine fibroids and uterine fibroid embolization (UFE), having performed more than 10,000 UFE treatments throughout his career. Since 2015, he has served as founder and medical director of the Atlanta Fibroid Center, a renowned outpatient medical center treating patients from around Atlanta, the United States and world. In addition to his medical practice, Dr. Lipman is an active public speaker and advocate, delivering regular lectures and making media appearances to ensure more widespread knowledge about uterine fibroids among both medical and general audiences.

“Dr. Goodwin and Dr. Spies have had a lasting and transformative impact on research into uterine fibroids and the safe and effective procedure of uterine artery embolization,” said Dr. Lipman. “I am inspired by their decades-long service as physicians, researchers, educators and advocates, and grateful to have this opportunity to support ongoing research into this historically underfunded area of care afflicting historically underserved women in particular.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”